CFTR and chronic obstructive pulmonary disease: This study also provides evidence that the CFTR modulator Trikafta could counteract the acquired CFTR dysfunction even in R75Q- or M470V-CFTR; thus, it may be applicable to a therapeutic approach to prevent COPD pathogenesis.